These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 20869877)

  • 21. A fully automated synthesis for the preparation of 68Ga-labelled peptides.
    Decristoforo C; Knopp R; von Guggenberg E; Rupprich M; Dreger T; Hess A; Virgolini I; Haubner R
    Nucl Med Commun; 2007 Nov; 28(11):870-5. PubMed ID: 17901771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of patients who have endocrine gastroenteropancreatic tumors with radiolabeled somatostatin analogues.
    Kwekkeboom DJ; Teunissen JJ; Kam BL; Valkema R; de Herder WW; Krenning EP
    Hematol Oncol Clin North Am; 2007 Jun; 21(3):561-73; x. PubMed ID: 17548040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimized conditions for chelation of yttrium-90-DOTA immunoconjugates.
    Kukis DL; DeNardo SJ; DeNardo GL; O'Donnell RT; Meares CF
    J Nucl Med; 1998 Dec; 39(12):2105-10. PubMed ID: 9867151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The radiometal makes a difference. Synthesis and preliminary characterisation of DOTA-minigastrin analogue complexes with Ga, Lu and Y.
    Maurin M; Garnuszek P; Baran P; Pawlak D; Mikołajczak R
    Nucl Med Rev Cent East Eur; 2015; 18(2):51-5. PubMed ID: 26315862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Semi-automated 86Y purification using a three-column system.
    Park LS; Szajek LP; Wong KJ; Plascjak PS; Garmestani K; Googins S; Eckelman WC; Carrasquillo JA; Paik CH
    Nucl Med Biol; 2004 Feb; 31(2):297-301. PubMed ID: 15013497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the stability of Y-90-, Lu-177- and Ga-68- labeled human serum albumin microspheres (DOTA-HSAM).
    Wunderlich G; Schiller E; Bergmann R; Pietzsch HJ
    Nucl Med Biol; 2010 Nov; 37(8):861-7. PubMed ID: 21055615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conjugation of DOTA-like chelating agents to peptides and radiolabeling with trivalent metallic isotopes.
    Sosabowski JK; Mather SJ
    Nat Protoc; 2006; 1(2):972-6. PubMed ID: 17406332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Octreotide and octreotate derivatives radiolabeled with yttrium: pharmacokinetics in rats.
    Laznicek M; Laznickova A; Mäcke HR; Eisenwiener K; Reubi JC; Wenger S
    Cancer Biother Radiopharm; 2002 Oct; 17(5):527-33. PubMed ID: 12470422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simplified NaCl based (68)Ga concentration and labeling procedure for rapid synthesis of (68)Ga radiopharmaceuticals in high radiochemical purity.
    Mueller D; Klette I; Baum RP; Gottschaldt M; Schultz MK; Breeman WA
    Bioconjug Chem; 2012 Aug; 23(8):1712-7. PubMed ID: 22755505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiolabeling of PAMAM dendrimers conjugated to a pyridine-N-oxide DOTA analog with ¹¹¹In: Optimization of reaction conditions and biodistribution.
    Biricová V; Lázničková A; Lázníček M; Polášek M; Hermann P
    J Pharm Biomed Anal; 2011 Nov; 56(3):505-12. PubMed ID: 21757312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Production and purification of gallium-66 for preparation of tumor-targeting radiopharmaceuticals.
    Lewis MR; Reichert DE; Laforest R; Margenau WH; Shefer RE; Klinkowstein RE; Hughey BJ; Welch MJ
    Nucl Med Biol; 2002 Aug; 29(6):701-6. PubMed ID: 12234596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Formulation and purification of therapeutic dose of
    Chakravarty R; Chakraborty S; Dash A
    Appl Radiat Isot; 2017 Mar; 121():1-5. PubMed ID: 28012419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. From octreotide to shorter analogues: Synthesis, radiolabeling, stability.
    Yakusheva A; Titchenko N; Egorova B; Matazova E; Podkhalyuzina N; Osipov V; Khachatryan D; Avdeev D; Posypanova G; Kalmykov S
    J Labelled Comp Radiopharm; 2019 Sep; 62(11):718-728. PubMed ID: 31410877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Labeling monoclonal antibodies with 90yttrium- and 111indium-DOTA chelates: a simple and efficient method.
    Li M; Meares CF; Zhong GR; Miers L; Xiong CY; DeNardo SJ
    Bioconjug Chem; 1994; 5(2):101-4. PubMed ID: 8031871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Semiautomated labelling and fractionation of yttrium-90 and lutetium-177 somatostatin analogues using disposable syringes and vials.
    Asti M; Atti G; Iori M; Farioli D; Filice A; Versari A
    Nucl Med Commun; 2012 Nov; 33(11):1144-52. PubMed ID: 22889932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of [(90)Y]DOTA-conjugated bisphosphonate for treatment of painful bone metastases.
    Ogawa K; Kawashima H; Shiba K; Washiyama K; Yoshimoto M; Kiyono Y; Ueda M; Mori H; Saji H
    Nucl Med Biol; 2009 Feb; 36(2):129-35. PubMed ID: 19217524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 68Ga-labelled DOTA-derivatised peptide ligands.
    Meyer GJ; Mäcke H; Schuhmacher J; Knapp WH; Hofmann M
    Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1097-104. PubMed ID: 15029459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiosynthesis of new [90Y]-DOTA-based maleimide reagents suitable for the prelabeling of thiol-bearing L-oligonucleotides and peptides.
    Schlesinger J; Fischer C; Koezle I; Vonhoff S; Klussmann S; Bergmann R; Pietzsch HJ; Steinbach J
    Bioconjug Chem; 2009 Jul; 20(7):1340-8. PubMed ID: 19552458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioorthogonal chemistry for (68) Ga radiolabelling of DOTA-containing compounds.
    Evans HL; Carroll L; Aboagye EO; Spivey AC
    J Labelled Comp Radiopharm; 2014 Apr; 57(4):291-7. PubMed ID: 24307493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 68Ga-autoclabeling of DOTA-TATE and DOTA-NOC.
    Blom E; Koziorowski J
    Appl Radiat Isot; 2012 Jun; 70(6):980-3. PubMed ID: 22480913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.